glp-1 therapies

  1. S

    Biocon Integrates Businesses with New CEO Leadership

    New Delhi, March 27 Biocon Ltd announced on Friday that Shreehas Tambe has been appointed as CEO & Managing Director, effective April 1, 2026.As the first CEO of the integrated Biocon, he will lead the combined platform encompassing biosimilars and generics, strengthening the company's ability...
Back
Top